Bio Medica Laboratories Ltd Share Price History
NSE : 12 Jun, 2026
134.5515.4 (12.9%)
Prev Close
119.2
Open Price
127.9
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
453000
Today's High / Low
136.5 / 121.0
52 WK High / Low
136.5 / 101.5
Market Price of Bio Medica Laboratories Ltd
1M
1Y
3Y
5Y
Monitoring Bio Medica Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2023 |
|---|---|
| Sales (Cr.) | 16 |
| Sales YoY Gr. | - |
| Adj EPS | 33.35 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 243.95 |
Key Financial Parameters
| Parameter | 2023 |
|---|---|
| Return on Capital Emp. % | 9.9 |
| Op. Profit Mgn % | 10.6 |
| Net Profit Mgn % | 2.03 |
| Debt to Equity % | 3.94 |
Latest Shareholding
Promoters Holdings Over Time
About Bio Medica Laboratories Ltd
- Bio Medica Laboratories Limited was originally incorporated as a private limited Company with the name of 'Bio Medica Laboratories Private Limited' vide certificate of Incorporation dated August 14, 2015, issued by Registrar of Companies, Gwalior.
- Further, the status got converted into a Public Company & name of the Company changed from 'Bio Medica Laboratories Private Limited' to 'Bio Medica Laboratories Limited' & Registrar of Companies, CPC has issued a new Certificate of Incorporation dated October 24, 2024. Company is engaged in the of manufacturing of Pharmaceutical Parenteral Formulations.
- It manufacture variety of products, comprising ethical drugs, generic drugs and over the-counter drugs (OTC) in the form of injectables namely Liquid Injections and Dry Powder Injections.
- These injectables are available in both single dose and multi dose forms, catering both human and veterinary needs.
Popular Search
FAQs for null Share Price History
What are the key events that typically impact Bio Medica Laboratories Ltd's share price history?
Key events that impact Bio Medica Laboratories Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Bio Medica Laboratories Ltd's share price history?
Stock splits reduce the nominal price of Bio Medica Laboratories Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Bio Medica Laboratories Ltd?
Dividends can influence Bio Medica Laboratories Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Bio Medica Laboratories Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Bio Medica Laboratories Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Bio Medica Laboratories Ltd’s share price history?
To understand Bio Medica Laboratories Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
